Global Cannabis Legalization Tracker
Track cannabis legalization worldwide — federal US developments, 36+ country profiles, and a complete timeline from 1996 to 2026. Every entry includes investment implications for cannabis stocks.
US Federal Status
Cannabis was reclassified from Schedule I to Schedule III by the DEA in November 2025, with the rule taking effect in January 2026. This eliminated the Section 280E tax burden and opened pathways for banking reform and research. Full legalization would require Congressional action.
Key Federal Developments
DEA Final Rule on Schedule III Rescheduling Published
The DEA published its final rule reclassifying cannabis from Schedule I to Schedule III of the Controlled Substances Act, effective 60 days from publication. The landmark decision ended decades of Schedule I classification and immediately eliminated the Section 280E tax burden on cannabis businesses. Industry analysts estimated the tax relief alone would improve cannabis company operating margins by 20-30 percentage points. Cannabis stocks rallied significantly, with major MSO shares gaining 40-60% in the days following the announcement. The reclassification also opened the door for expanded research and potential pharmaceutical development pathways.
SAFE Banking Act Reintroduced with Bipartisan Support
A bipartisan coalition reintroduced the SAFE Banking Act in both the House and Senate with over 60 Senate cosponsors, representing the strongest Senate support the bill had ever received. The updated bill included provisions for cannabis business access to traditional banking, credit card processing, insurance, and SBA loans. Industry advocates expressed cautious optimism that the broad cosponsor count could finally translate to Senate passage, though timing and floor scheduling remained uncertain. The cannabis banking crisis continued to pose safety and operational challenges for state-legal operators.
DEA Administrative Hearing on Rescheduling Begins
The DEA commenced formal administrative law judge hearings on the proposed rescheduling of cannabis from Schedule I to Schedule III. Multiple parties including cannabis industry groups, medical organizations, and prohibition advocates participated in the proceedings. The hearings were expected to evaluate scientific evidence, medical utility, and abuse potential of cannabis. The administrative process introduced uncertainty about the timeline and outcome of rescheduling, with some analysts projecting a final rule could take until late 2025 or 2026. Markets remained volatile as hearing updates emerged.
SAFE Banking Passes Senate Committee
The Senate Banking Committee approved the SAFER Banking Act (an updated version of the SAFE Banking Act) on a bipartisan vote, advancing cannabis banking reform further than it had ever progressed in the Senate. The bill included provisions protecting financial institutions from federal penalties for serving cannabis businesses, as well as anti-money laundering provisions. Despite committee passage, the full Senate did not schedule a floor vote during the session, continuing the pattern of near-misses that has characterized cannabis banking reform efforts in Congress.
DEA Proposes Rule to Reschedule Cannabis to Schedule III
The Drug Enforcement Administration published a proposed rule to transfer cannabis from Schedule I to Schedule III of the Controlled Substances Act, following the HHS recommendation. The proposed rule initiated a public comment period and potential administrative law judge hearings. Schedule III reclassification would not legalize cannabis but would remove the Section 280E tax burden, allow for more research, and potentially open some banking access. Cannabis stocks experienced significant volatility around the announcement, with initial enthusiasm tempered by the recognition that the rulemaking process could take years to complete.
View all 16 federal developments
HHS Recommends Rescheduling Cannabis to Schedule III
The Department of Health and Human Services formally recommended to the DEA that cannabis be rescheduled from Schedule I to Schedule III of the Controlled Substances Act, following the review ordered by President Biden. The recommendation was based on an FDA scientific review concluding that cannabis has a currently accepted medical use, a lower potential for abuse than Schedule I substances, and a moderate to low potential for physical dependence. This recommendation sent cannabis stocks surging, as Schedule III classification would eliminate the punitive Section 280E tax provision that has cost the industry billions of dollars in excess federal taxes.
Biden Issues Mass Pardon for Federal Cannabis Possession
President Biden announced a mass pardon for all prior federal offenses of simple possession of marijuana, affecting approximately 6,500 individuals convicted under federal law. He simultaneously directed the Department of Health and Human Services and the Attorney General to review how cannabis is scheduled under federal law. This was the most significant presidential action on cannabis reform in US history. The scheduling review directive set in motion the process that would eventually lead to DEA rescheduling proceedings, representing a potential paradigm shift in federal cannabis policy.
Senate Cannabis Administration and Opportunity Act Draft Released
Senate Majority Leader Chuck Schumer, along with Senators Booker and Wyden, released a draft of the Cannabis Administration and Opportunity Act (CAOA). The comprehensive bill proposed federal descheduling, social equity programs, automatic expungement, and FDA regulation of cannabis products. The bill was notable for its breadth but faced criticism from some industry stakeholders for its proposed tax structure and from moderate senators who preferred incremental reform through banking legislation first. The CAOA was formally introduced in 2022 but did not receive a Senate floor vote.
MORE Act Passes House
The House passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which would deschedule cannabis entirely from the Controlled Substances Act, establish a federal tax on cannabis sales, and create programs for communities disproportionately affected by the War on Drugs. This marked the first time a chamber of Congress voted to end federal cannabis prohibition. The Senate did not advance the bill, but the vote represented a watershed moment for the cannabis legalization movement and signaled that full federal legalization was politically viable at the national level.
SAFE Banking Act Passes House
The House of Representatives passed the Secure and Fair Enforcement (SAFE) Banking Act by a vote of 321-103, marking the first time either chamber of Congress passed standalone cannabis reform legislation. The bill would protect banks and financial institutions from federal penalties for providing services to state-legal cannabis businesses. Despite its broad bipartisan support, the Senate did not take up the bill. The SAFE Banking Act has subsequently passed the House multiple additional times, consistently demonstrating strong support, but Senate action remained elusive through multiple congressional sessions.
2018 Farm Bill Legalizes Hemp
President Trump signed the Agriculture Improvement Act of 2018, which removed hemp (cannabis with less than 0.3% THC) from the Controlled Substances Act. The bill legalized hemp cultivation, processing, and sale nationwide, creating a new agricultural commodity and enabling the explosion of the CBD industry. The Farm Bill established USDA oversight of hemp production and allowed interstate commerce in hemp products. This was the first removal of any cannabis-related substance from federal prohibition and opened the door for hemp-derived cannabinoid products that have since grown into a multi-billion dollar market segment.
STATES Act Introduced
Senators Elizabeth Warren and Cory Gardner introduced the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, which would amend the Controlled Substances Act to exempt state-compliant cannabis activities from federal prohibition. The bill represented one of the most significant bipartisan cannabis reform proposals in Congress and garnered support from President Trump. While the bill did not advance to a vote during its initial session, it established the framework for subsequent states' rights approaches to cannabis reform and demonstrated growing bipartisan support for ending federal interference with state cannabis programs.
Sessions Rescinds Cole Memo
Attorney General Jeff Sessions rescinded the Cole Memorandum, issuing a one-page memo returning cannabis enforcement discretion to individual US Attorneys. The move sent shockwaves through the cannabis industry, with stock prices dropping sharply across the sector. However, the practical impact proved minimal — no US Attorney launched new enforcement actions against state-legal operations. The rescission highlighted the fragility of relying on executive guidance rather than legislation, and accelerated congressional efforts to pass permanent cannabis reform. Cannabis stocks largely recovered within weeks as it became clear that enforcement practices would not materially change.
Rohrabacher-Farr Amendment Passes
Congress passed the Rohrabacher-Farr Amendment (later renamed Rohrabacher-Blumenauer) as a rider to the federal spending bill, prohibiting the Department of Justice from using federal funds to interfere with state medical cannabis programs. This was the first time Congress took legislative action to protect state-legal cannabis operations from federal prosecution. The amendment must be renewed with each spending bill, creating periodic uncertainty, but it has been consistently renewed since 2014. It applies only to medical cannabis programs, leaving recreational operations without explicit congressional protection.
Cole Memorandum Issued
Deputy Attorney General James Cole issued a memorandum directing federal prosecutors to deprioritize enforcement of federal cannabis laws in states with robust regulatory frameworks. The memo outlined eight enforcement priorities including preventing distribution to minors and preventing revenue from going to criminal enterprises. This guidance effectively created a federal safe harbor for state-legal cannabis operations, giving the nascent industry room to develop. The Cole Memo became the foundational document underpinning the legal cannabis industry's growth across the United States, providing comfort to investors, banks, and operators that federal enforcement would remain limited.
Colorado and Washington Become First States to Legalize Recreational Cannabis
Voters in Colorado (Amendment 64) and Washington (Initiative 502) approved ballot measures legalizing recreational cannabis for adults 21 and over, making them the first jurisdictions in the world to legalize cannabis through popular vote. The measures established regulatory frameworks for commercial cultivation, processing, and retail sales. Colorado's first recreational dispensaries opened on January 1, 2014, while Washington's followed in July 2014. These historic votes launched the modern era of cannabis legalization and demonstrated that regulated cannabis markets could function alongside existing alcohol and tobacco frameworks.
Countries by Region
North America(3)
Europe(14)
Germany
Netherlands
Luxembourg
Malta
Czech Republic
Portugal
Spain
Italy
Switzerland
United Kingdom
France
Denmark
Poland
Greece
South America(7)
Asia-Pacific(6)
Legalization Timeline
Major milestones in global cannabis legalization from 1996 to present.
Schedule III Reclassification Takes Effect
The DEA's final rule reclassifying cannabis to Schedule III officially takes effect.
DEA Finalizes Schedule III Reclassification
Cannabis officially reclassified from Schedule I to Schedule III, ending 280E tax burden.
SAFE Banking Act Reintroduced with 60+ Senate Cosponsors
Cannabis banking reform bill receives strongest Senate support ever with 60+ cosponsors.
Germany Legalizes Recreational Cannabis
Germany implements partial legalization allowing personal possession and home cultivation.
DEA Proposes Cannabis Rescheduling Rule
The DEA publishes a proposed rule to reschedule cannabis from Schedule I to Schedule III.
Brazil Supreme Court Decriminalizes Personal Possession
Brazil's Supreme Court rules personal cannabis possession up to 40g cannot be criminalized.
HHS Recommends Rescheduling Cannabis to Schedule III
HHS formally recommends to the DEA that cannabis be reclassified from Schedule I to Schedule III.
Luxembourg Legalizes Home Cultivation
Luxembourg legalizes home growing of up to 4 cannabis plants for personal use.
Thailand Decriminalizes Cannabis
Thailand removes cannabis from its narcotics list, leading to rapid market proliferation.
Biden Issues Mass Cannabis Pardon
President Biden pardons federal cannabis possession offenses and orders scheduling review.
Malta First EU Country to Legalize Recreational Cannabis
Malta passes legislation allowing home cultivation and cannabis social clubs.
France Launches Medical Cannabis Experiment
France begins its medical cannabis experimentation program for specific patient populations.
Morocco Legalizes Medical Cannabis Cultivation
Morocco legalizes cannabis cultivation for medical and industrial purposes.
US House Passes MORE Act
The House votes to deschedule cannabis for the first time in congressional history.
Five US States Approve Cannabis Measures
Arizona, Montana, New Jersey, South Dakota approve recreational; Mississippi approves medical.
ACT Legalizes Recreational Cannabis
Australian Capital Territory becomes first Australian jurisdiction to legalize personal cannabis use.
Canada Legalizes Recreational Cannabis Nationwide
Canada becomes the first G7 nation to legalize recreational cannabis with the Cannabis Act.
South Africa Court Rules Personal Use Constitutional
South Africa's Constitutional Court rules personal cannabis use in private is constitutionally protected.
US Farm Bill Legalizes Hemp
The 2018 Farm Bill removes hemp from the Controlled Substances Act, launching the CBD industry.
UK Legalizes Medical Cannabis
The UK reschedules cannabis-based products for medical use following high-profile patient cases.
Thailand Legalizes Medical Cannabis
Thailand becomes the first Southeast Asian country to legalize medical cannabis.
South Korea Legalizes Medical Cannabis
South Korea becomes the first East Asian country to legalize specific cannabis-based medicines.
Germany Legalizes Medical Cannabis
Germany establishes its medical cannabis program, becoming Europe's largest medical market.
Lesotho Issues First African Cannabis License
Lesotho becomes the first African country to grant a license for medical cannabis cultivation.
California, Nevada, Massachusetts, Maine Legalize Recreational
Four states legalize recreational cannabis in a single election, including the nation's largest market.
Australia Legalizes Medical Cannabis
Australia amends the Narcotic Drugs Act to permit medical cannabis cultivation and access.
Colorado Opens First Recreational Dispensaries
Colorado becomes the first jurisdiction to open legal recreational cannabis retail stores.
Rohrabacher-Farr Amendment Passes
Congress prohibits federal interference with state medical cannabis programs for the first time.
Uruguay Legalizes Cannabis Nationwide
Uruguay becomes the first country in the world to fully legalize recreational cannabis at the national level.
Cole Memorandum Issued
US Deputy AG issues guidance deprioritizing federal cannabis enforcement in compliant states.
Colorado and Washington Legalize Recreational Cannabis
Voters in Colorado and Washington become the first to legalize recreational cannabis through ballot measures.
Portugal Decriminalizes All Drugs
Portugal becomes the first country to decriminalize personal possession of all drugs including cannabis.
Israel Medical Cannabis Program Begins
Israel establishes one of the world's first formal medical cannabis programs.
California Passes Proposition 215
California becomes the first US state to legalize medical cannabis with the Compassionate Use Act.